| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $649.0M | $723.4M | $835.5M |
| YoY Revenue Growth % | -10.3% | -13.4% | — |
| Gross Profit | $68.4M | $73.1M | — |
| Gross Margin % | 10.5% | 10.1% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$656.0K | -$758.0K | $39.9M |
| Operating Margin % | -0.1% | -0.1% | 4.8% |
| Net Income (GAAP) | -$20.5M | -$35.7M | $49.4M |
| EBITDA (Normalized) | $7.9M | $14.1M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $44.6M | -$33.5M | $38.3M |
| Capital Expenditures (CapEx) | $10.7M | $18.5M | — |
| Free Cash Flow (FCF) | $34.0M | -$52.0M | $38.3M |
| FCF Margin % | 5.2% | -7.2% | 4.6% |
| Return on Invested Capital (ROIC %) | -0.2% | -0.2% | — |
| Cash & Short-Term Equivalents | — | — | — |
| Total Debt (Short + Long Term) | $104.0M | $127.1M | — |
| Total Stockholders' Equity | $133.4M | $135.6M | — |